CD4+/CD56+ hematodermic neoplasm: Report of a rare variant with a T-cell receptor gene rearrangement

Journal of Cutaneous Pathology

Volumn 35, Issue 6, 2008, Pages 579-584

  Stetsenko, Galina Y ^a,b   McFarlane, Rob ^a   Kalus, Andrea ^b   Olerud, John ^b   Cherian, Sindhu ^a   Fromm, Jonathan ^a   George, Evan ^a   Argenyi, Zsolt ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

ADULT; ANAMNESIS; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE COURSE; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE REARRANGEMENT; HEMATODERMIC NEOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PROPHYLAXIS; PUNCH BIOPSY; SKIN BIOPSY; SKIN CANCER; SKIN MANIFESTATION; STEM CELL TRANSPLANTATION; T LYMPHOCYTE RECEPTOR GENE;

ANTIGENS, CD4; ANTIGENS, CD56; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DNA, NEOPLASM; DOXORUBICIN; FLOW CYTOMETRY; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 43349083085     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00845.x     Document Type: Article

References (28)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768.
2. Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In Jaffe ES, Harris NL, Stein H and Vardiman JW. Tumouers of haematopoietic and lymphoid tissues. Lyon, France : IARC Press, 2001 214.
3. Petrella T, Comeau MR, Maynadie M, et al. Agranular CD4+CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates form a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002 26 : 852.
4. Petrella T, Meijer CJ, Dalac S, et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol 2004 122 : 307.
5. Reichard KK, Burks EJ, Foucar MK, et al. CD4(+)CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol 2005 29 : 1274.
6. Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001 97 : 3210.
7. Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N182CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994 47 : 278.
8. Kato N, Yasukawa K, Kimura K, et al. CD2-CD4+CD56+ hematodermic/ hematolymphoid malignancy. J Am Acad Dermatol 2001 44 : 231.
9. Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 2005 123 : 662.
10. Bekkenk M, Jansen P, Meijer C, et al. CD56+ hematologic neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004 15 : 1097.
11. Assaf C, Gellrich S, Whittaker S, et al. CD56 lymphoproliferative disorders of the skin: a multicenter study of the cutaneous lymphoma project of the European organization for research and treatment of cancer (EORTC). J Clin Pathol 2006 (epub ahead of print).
12. Cong P, Pffeld M, Jaffe ES. Blastic NK cell lymphoma/leukemia: a clinicopathological study of 23 cases. Mod Pathol 2001 14 : 160A.
13. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002 2 : 151.
14. Jacob MC, Chaperot L, Mossuz P, et al. CD4+CD56+lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003 88 : 941.
15. Petrella T, Dalac S, Maynadie M, et al. CD4+CD56+ cutaneous neoplasm: a distinct hematologic entity? Groupe Francais d'Etude des Lymphones Cutanes (GFELC). Am J Surg Pathol 1999 23 : 137.
16. Aoyama Y, Yamane T, Hino E, et al. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement. Ann Hematol 2001 80 : 752.
17. Liu XY, Atkins R, Feuster J, et al. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement. Am J Hematol 2004 75 : 251.
18. Bastian BC, Ott G, Muller-Deubert S, et al. Primary cutaneous natural killer/T-cell lymphoma. Arch Dermatol 1998 134 : 109.
19. Penven K, Macro M, Salaun V, et al. Skin manifestations in CD4+, CD56+ malignancies. Eur J Dermatol 2003 13 : 161.
20. Dijkman R, van Doorn R, Szuhai K, et al. Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 2007 109 : 1720.
21. Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin. A morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol 2004 28 : 719.
22. Witzens M, Mohler T, Willhauck M, et al. Detection of clonally rearranged T-cell receptor gamma chain genes from T-cell malignancies and acute inflammatory rheumatic disease using PCR amplification, PAGE, and automated analysis. Ann Hematol 1997 74 : 123.
23. Urosevic M, Conrad C, Kamarashev J, et al. CD4+CD56+hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol 2005 35 : 1020.
24. Kazakov D, Mentzel T, Burg, et al. Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol 2003 149 : 869.
25. Miller J, McCullar V, Punzel M, et al. Single adult human CD34(+)/Lin-CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cell, and myeloid cells. Blood 1999 93 : 96.
26. Feuillard J, Jacob M, Valensi F, et al. Clinical and biologic features of CD4+ CD56+ malignancies. Blood 2002 99 : 1556.
27. Martin P, del Hoyo G, Anjuere F, et al. Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(-) and CD8alpha (+) dendritic cells are generated from CD4(low) lymphoid-committed precursors. Blood 2000 96 : 2511.
28. Wood G. T-cell receptor and immunoglobulin gene rearrangements in diagnosing skin disease. Arch Dermatol 2001 137 : 1503.